Intellectual Property India Publishes Patent Application for Heteroaryl Compounds As Multi-Target Protein Kinase Inhibitors

MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202637090218 A) filed by Fujian Haixi Pharmaceuticals Co. , Ltd. on July 24, 2026, for Heteroaryl Compounds As Multi-Target Protein Kinase Inhibitors.

Inventors include Wang, Ruyong; Zhang, Fengsen; Lian, Xin; Li, Hengdong; Gong, Xuan; Lin, Daqiang; Zheng, Zhipeng; Chen, Xin; Wu, Xueyin; Sun, Hongxue; Zhang, Yuxuan; Qiu, Lili; Li, Junqing; Chen, Guangming; and Kang, Xinshan.

The application for the patent was published on September 25, 2026, under issue no. 39/2026.

Abstract: The present disclosure provides compounds of formula (I) having receptor protein tyrosine kinase activity, and a pharmaceutically acceptable salt, stereoisomers, isotopic isomers thereof. The compounds of the present disclosure have high biological activity and can be used to treat diseases or disorders related to the target.

Disclaimer: Curated by HT Syndication.